# Elina Onitskansky

> Elina Onitskansky is the founder and CEO of Ilant Health and a senior advisor at Valeas Capital Partners. A Harvard chemistry and physics graduate with an MBA from Harvard Business School, she previously held leadership roles at McKinsey, Molina Healthcare, and Help at Home, and worked in private equity at Hellman & Friedman. Her company announced a $15 million Series A in June 2026.

- **Role:** Founder and CEO at Ilant Health
- **Organizations:** Ilant Health, Valeas Capital Partners, Centerbridge Partners, Help at Home, Molina Healthcare, McKinsey & Company, Hellman & Friedman, Journal of Young Investigators, Carter Burden Network
- **Education:** A.B. in Chemistry and Physics, magna cum laude, Harvard College, MBA, with distinction, Harvard Business School
- **Known for:** Harvard College A.B., magna cum laude., Harvard Business School MBA, with distinction., Led the Journal of Young Investigators as CEO during her undergraduate years.

## Career timeline

- **2001** — Named as a co-inventor on published US patent application US20010042693A1 for a sensor detecting trace metal ions in water; the application was assigned to Hathaway Brown School.
- **2005** — Identified as CEO of the Journal of Young Investigators while at Harvard University.
- **2008-2010** — Worked as an associate at Hellman & Friedman.
- **2012** — Earned an MBA from Harvard Business School.
- **2016-2018** — Served as an associate partner at McKinsey & Company.
- **2018-2021** — Led strategy at Molina Healthcare, including as Senior Vice President and Head of Strategy.
- **2021-2022** — Served as Chief Growth and Strategy Officer at Help at Home.
- **2022** — Founded Ilant Health; also began an executive-in-residence role at Centerbridge Partners.
- **2022** — Joined Valeas Capital Partners as a senior advisor, according to Valeas’s own biography.
- **2023** — Ilant Health publicly launched with $3 million in funding.
- **2024** — Recognized among Rock Health’s System Disruptors, according to her Business Group on Health speaker biography.
- **2026** — Ilant Health announced a $15 million Series A led by Cornucopian Capital in June.

## Achievements

- Harvard College A.B., magna cum laude.
- Harvard Business School MBA, with distinction.
- Led the Journal of Young Investigators as CEO during her undergraduate years.
- Co-inventor named on published sensor patent application US20010042693A1; this is an application, not a claim of an awarded patent.
- Founded Ilant Health, which announced a $15 million Series A in June 2026.

## Latest updates

- **2026-06** — Ilant Health announced a $15 million Series A led by Cornucopian Capital, bringing reported total funding above $22 million.
- **2026-07** — Participated in a company presentation and Q&A with Kevin O’Leary at Health Tech Nerds on July 28.
- **2026-09** — Featured in a CB Insights CEO interview published September 21.

## Links

- Website: https://www.ilanthealth.com/
- LinkedIn: https://www.linkedin.com/in/elinaonitskansky/

---

Profile page: https://yespress.io/elina-onitskansky
Published by YesPress — https://yespress.io
Last updated: 2026-10-22